Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

George Williams (NPI 1558393405)

Field	Value
Entity Type	Individual
Organization	George Williams
Address	3555 W 13 Mile Rd
City	Royal Oak
State	MI
ZIP	48073
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	July 7, 2006

Payer Source	Total Paid
Medicare	$2.7M
Medicaid	$0

Key Findings

This provider is effectively single‑payer: reported lifetime Medicare revenue is $2.7M and there is no Medicaid billing on file, so Medicare dominates the observable payer mix for this NPI. Analysts should treat Medicare patterns as representative of the provider’s entire public-payer footprint.

Revenue is highly concentrated: the precomputed top‑3 Medicare codes account for 83.5% of the provider’s Medicare revenue, with a single code J0178 representing 54.7% of Medicare revenue and J2778 contributing 20.6%. That concentration indicates the practice’s financial performance is driven overwhelmingly by a small set of anti‑VEGF injection services and high‑level office visits.

The code mix reflects a medical retina practice built around intravitreal pharmacologic therapy and associated office management: high‑revenue J0178 (aflibercept) and J2778 (ranibizumab) and the intravitreal procedure code 67028 are the primary revenue drivers, while 99214 appears among the top revenue codes for office E/M. Complementary diagnostic imaging is also used routinely (see 92134), consistent with ongoing active management of retinal disease.

On anti‑VEGF utilization the provider is a solid national participant but not uniquely dominant: J0178 ranks #452 of 3204 (86th percentile; typical, unremarkable volume for this code) and J2778 ranks #104 of 1208 (91th percentile; typical, unremarkable volume for this code). These placements indicate comparatively high but still typical volumes for those drugs versus national peers rather than an outlier market position.

Operational intensity is an outlier for office management and retinal imaging: 99214 ranks #652 of 479517 (100th percentile; extreme outlier, far above typical national volume for this code) and 92134 ranks #727 of 26868 (97th percentile; extreme outlier, far above typical national volume for this code). Together these rankings suggest unusually high visit counts and OCT/retinal imaging throughput relative to national peers, implying a high‑volume follow‑up model for chronic retinal disease.

The practice shows some service diversification beyond aflibercept/ranibizumab: J2777 (faricimab) appears with 3.5K claims and $102.7K revenue (3.7%) but ranks low nationally (14th percentile; typical), while J7312 (dexamethasone implant) and J3490 (unclassified drugs) contribute smaller shares ($27.5K and $35.9K respectively) and sit at lower national percentiles. This mix indicates adoption of multiple intravitreal therapies and occasional use of higher‑cost or unclassified agents, but these do not materially change the revenue concentration.

Because a single code, J0178, accounts for a majority share (54.7%) and the top three codes make up 83.5% of Medicare revenue, the provider’s revenue is sensitive to shifts in utilization patterns or reimbursement for those specific drugs and associated visit codes. Payer or clinical pathway changes affecting anti‑VEGF prescribing, frequency, or reimbursement could materially impact total Medicare revenue.

The NPI was enumerated on 2006-07-07 (~20 years ago), indicating long tenure in the Medicare program; that longevity plausibly supports the high cumulative volumes and established referral/management patterns seen in the E/M and imaging outlier metrics. Analysts evaluating network contracting or capacity should factor in this extended presence as it relates to patient volume stability and operational scale.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,170	$690	$1.5M
J2778	Injection, ranibizumab, 0.1 mg	3,130	$180	$566.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	2,390	$90	$224.5K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,530	$100	$156.3K
J2777	Injection, faricimab‑svoa, 0.1 mg	3,540	$30	$102.7K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,390	$30	$71.5K
J3490	Unclassified drugs	20	$1,790	$35.9K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	180	$150	$27.5K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	130	$120	$16K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	150	$90	$13.2K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

George Williams — 3 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	10	110	680	$690	$630.2K
J2777	46	60	7,200	$30	$321K
J2778	5	50	730	$180	$240.5K
67028	17	160	440	$90	$57.6K
J7312	12	10	230	$150	$36.1K
92014	384	1,080	100	$80	$14.8K
99214	2	15,470	80	$80	$11.4K
92235	21	100	40	$100	$7.8K
J3490	42	50	40	$120	$7.2K
92134	12	820	60	$30	$7.1K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with George Williams, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
William Beaumont Hospital	MI	Hospitalist Physician	$0	$167.9M
Oakwood Healthcare, Inc.	MI	General Acute Care Hospital	$0	$165.3M
William Beaumont Hospital	MI	General Acute Care Hospital	$0	$162.4M
William Beaumont Hospital	MI	General Acute Care Hospital	$0	$84.8M
Oakwood Ambulatory LLC	MI	Internal Medicine Physician	$0	$66.9M
William Beaumont Hospital	MI	General Acute Care Hospital	$0	$61.5M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Wellstreet Urgent Care Of Michigan	MI	Urgent Care Clinic/Center	$0	$37.5M
Somc Medical Care Foundation, Inc.	OH	Family Medicine Physician	$0	$25.3M
Associated Retinal Consultants, PC	MI	Ophthalmology Physician	$0	$21.1M

Nearby Providers

Other providers in the same ZIP code as George Williams, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Judson Center, Inc.	MI	Community/Behavioral Health Agency	$0	$21.2M
Allergy & Asthma Associates Of Mi PC	MI	Allergy & Immunology Physician	$0	$15.9M
Community Homes, Inc.	MI	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$7.5M
Sandeep Randhawa	MI	Retina Specialist (Ophthalmology) Physician	$7M	$0
American Anesthesiology Of Michigan PC	MI	Anesthesiology Physician	$0	$5.7M
Joshua Robinson	MI	Ophthalmology Physician	$3.7M	$0
Jeremy Wolfe	MI	Retina Specialist (Ophthalmology) Physician	$3.7M	$0
Tamer Mahmoud	MI	Retina Specialist (Ophthalmology) Physician	$2.8M	$0
Kimberly Drenser	MI	Retina Specialist (Ophthalmology) Physician	$2.7M	$0
Alan Ruby	MI	Ophthalmology Physician	$2.4M	$0

George Williams — Billing Profile & Reimbursement Data

Sign up for George Williams — Billing Profile & Reimbursement Data policy alerts

George Williams — Billing Profile & Reimbursement Data

Sign up for George Williams — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References